Search results
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Zacks· 2 days agoFree Report) and Captain T Cell, a spinoff from Max Delbrück Center in Germany, entered into an...
New research points to 'stem-like' T cells as culprits in ulcerative colitis
Medical Xpress· 3 hours ago"We've found a population of T cells that may be important in disease—and may contribute to relapse in patients with ulcerative colitis," says LJI William K. Bowes Distinguished Professor Pandurangan ...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 6 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
T-cell manufacturing: When is the right time to automate?
Clinical Trials Arena via Yahoo Finance· 2 days agoAdvances in automation in T-cell production are beginning to help make life-changing therapies more...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 7 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
Charles River and Captain T Cell sign vector production agreement
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe alliance is a strategic move for Captain T Cell as it prepares to manufacture a TCR-T cell ...
Cellular Fountain of Youth: New T-Cell Discovery Rewrites the Rules of Aging
SciTechDaily· 16 hours agoMost cell types undergo functional decline after extensive proliferation and replication over the...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 2 days agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke
MedPage Today· 5 days agoTTHealthWatch is a weekly podcast from Texas Tech. This week's topics include eye training to...
CAR-T therapy achieves lupus remission breakthrough
BioPharma-Reporter· 1 day agoThis is the first trial to date to show safe elimination of all autoantibodies in patients with systemic lupus erythematosus (SLE) and lupus nephritis...